RxDoctor Payments Data

Samuel Hou

Neuroradiology · Burbank, CANPI 1932421625

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $13,550 of the $21,415 with a category attached, or 63.3%. Stryker accounts for 81.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $7,215 and has fallen 50.9% since, to $3,543 in 2025.

$21,415in general payments, 2019–2025

Across 132 payments — averaging $162.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$17K
  • Penumbra, Inc.$1K
  • Imperative Care, Inc$538
  • Microvention, Inc.$537
  • Medtronic$493
  • Johnson & Johnson$423
  • plus $660 from 9 others

What the payments were for

  • Consulting fees$13,55063%
  • Travel & lodging$1,5277%
  • Food & beverage$6,33830%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,415 in reported general payments places this provider in the 80th percentile of 154 neuroradiology providers in California.

See all neuroradiology providers in California

Medicare billing

Part B allowed, 2024
$109,475
Medicare patients
101
Services billed
459

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor18$10,420

Paid to pharmacies, not to this prescriber.

Other neuroradiology in Burbank

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →